Financial information

Key figures

In € million except share and per share data
2023

2022

2021

2020

2019
Revenue7.910.317.49.913.7
R&D Expense-29.6-32.2-32.9-27.3-31.4
G&A Expense-7.0-7.9-7.4-6.5-7.1
Net income (loss)-22.3-32.8-19.5-17.2-18.8
Net Cash Burn-24.0-22.8-10.0-17.0-20.5
Cash & Cash Equivalents15.726.849.626.343.3
Earnings/Loss per Share (Basic)-0.22-0.33-0.21-0.21-0.23
Earnings/Loss per Share (Diluted)-0.22-0.33-0.20-0.21-0.23
Shares Outstanding100,852,742100,204,07197,771,33483,841,33483,265,464
Financial reports

YearsQuarterInterimRegistration Document
FirstSecondThirdFourth
2024      
2023          XBRL(fr)    Amendment(fr)    
2022       XBRL(fr)
2021        XBRL(fr)
2020      
2019      
2018      
2017      
2016      
2015        
2014      
Regulated information

Chairman’s report on corporate governance and internal controls Statutory Auditors’ fees

Annual General Meeting information

Rights issue

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00

 

© 2023 Transgene - All rights reserved
Credits